Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Open-label Trial of Stelara (ustekinumab) in Patients with Pyoderma gangrenosum
2011-002920-41Phase 2Terminated
- Sponsor
- University Hospital Tübingen
- Start
- Aug 2011
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of ustekinumab in pyoderma gangrenosum (PG), sponsored by University Hospital Tübingen. Primary endpoint: Change in PG-inflammation score. Started Aug 2011; status: terminated.
02
Drugs
ustekinumab
03
Conditions
pyoderma gangrenosum (PG)
Beyond the preview
Go deeper on 2011-002920-41.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-002920-41.